SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen in Non-Invasive Breast Cancer
By
SABCS 2022 Conference Coverage
FEATURING
Andrea De Censi
By
SABCS 2022 Conference Coverage
FEATURING
Andrea De Censi
1,497 views
December 15, 2022
Comments 0
Login to view comments.
Click here to Login
Videos